Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors (2020)
- Authors:
- Autor USP: MUSSI, MARISA MARCIA - FMRP
- Unidade: FMRP
- DOI: 10.1371/journal.pone.0242405
- Subjects: TERAPIA ANTIRRETROVIRAL DE ALTA ATIVIDADE; FARMACOTERAPIA; PEDIATRIA; HIV; CRIANÇAS
- Keywords: Antiretroviral therapy; Protease inhibitor therapy; Drug therapy; Protease inhibitors; Pediatrics; Reverse transcriptase inhibitors; Questionnaires; Drug adherence
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: San Francisco
- Date published: 2020
- Source:
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
YIN, Dwight E. et al. Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors. PLOS ONE, v. 15, n. 11, p. 1-18, 2020Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0242405. Acesso em: 31 mar. 2026. -
APA
Yin, D. E., Ludema, C., Cole, S. R., Golin, C. E., Miller, W. C., Warshaw, M. G., et al. (2020). Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors. PLOS ONE, 15( 11), 1-18. doi:10.1371/journal.pone.0242405 -
NLM
Yin DE, Ludema C, Cole SR, Golin CE, Miller WC, Warshaw MG, McKinney Jr. RE, Mussi-Pinhata MM. Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors [Internet]. PLOS ONE. 2020 ; 15( 11): 1-18.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1371/journal.pone.0242405 -
Vancouver
Yin DE, Ludema C, Cole SR, Golin CE, Miller WC, Warshaw MG, McKinney Jr. RE, Mussi-Pinhata MM. Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors [Internet]. PLOS ONE. 2020 ; 15( 11): 1-18.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1371/journal.pone.0242405 - Quality assurance program for peripheral blood mononuclear cell cryopreservation
- Neurologic outcomes in HIV-exposed/uninfected infants exposed to antiretroviral drugs during pregnancy in Latin America and the Caribbean
- Undervaccination of perinatally HIV-infected and HIV-exposed uninfected children in Latin America and the Caribbean
- Clinical profile of HIV-infected adolescents in Latin America: preliminary report of NICHD international site development initiative pediatric study
- Recem-nascido de baixo peso
- NICDH International Site Developmental Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries
- Laboratory-based surveillance of streptococcus pneumoniae invasive disease (IPD) in children: serotype distribution and estimation of vaccines coverage
- Lower respiratory tract infections among human immunodeficiency virus-exposed, uninfected infants
- Congenital and perinatal cytomegalovirus infection
- Altered natural killerr cell function in HIV-exposed uninfected infants
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003048359.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
